Childhood cancer survivors may benefit from early MRI breast cancer screening.
Early MRI-based breast cancer screening of females treated with radiation therapy for childhood cancer can reduce breast cancer mortality in this patient group, according to a study published in the Journal of the National Cancer Institute.
Researchers from Canada sought to determine the benefit of early breast cancer screening of female childhood cancer survivors who had undergone thoracic radiation therapy (RT). The researchers searched through published studies that reviewed the risk of breast cancer in survivors of childhood lymphoma, and used a mathematical model of breast cancer development to quantify the effectiveness of screening starting at age 25 among women who had undergone chest RT as children.
The results showed that overall, survivors who were 15 years old when they received RT had an absolute risk of 16.65 percent of BC mortality by age 75 years. However, this risk decreased with regular screening:
“Approximately 80 patients would need to be invited to MRI-based screening to prevent one BC death,” the authors wrote. Combining MRI and mammography would likely produce 99.52 false positives per 1,000 screenings of women between 25 and 39 years.
"If you are a young woman who was treated with radiation therapy to your chest as a teenager or child for [Hodgkin’s lymphoma], or for that matter chest radiation therapy for any reason, you should be having a conversation with your family doctor or your oncologist about whether to start breast cancer screening earlier than most women would," principal investigator David Hodgson, MD, professor in the department of radiation oncology, faculty of medicine, University of Toronto, said in a release.
Because of the increased risk of false positives in this age group, Hodgson said in the release: This is important for patients to know and for physicians to counsel patients about because it's stressful for a patient to be called back about suspicious findings.
The researchers concluded that early breast cancer screening with MRI for women who received RT for childhood cancers is beneficial and will reduce breast cancer mortality.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Emerging AI Software for Prostate MRI Offers 95 Percent Sensitivity for csPCa
February 28th 2025In a multicenter study involving over 1,000 patients, a deep learning software offered comparable sensitivity and specificity for Gleason grade group > 2 tumors in comparison to radiologist interpretation.